Detalles de la búsqueda
1.
Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment.
Breast Cancer Res Treat
; 196(2): 423-437, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36114323
2.
Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer.
Breast Cancer Res Treat
; 192(1): 113-122, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039952
3.
Changes in serum estradiol levels with Estring in postmenopausal women with breast cancer treated with aromatase inhibitors.
Support Care Cancer
; 29(1): 187-191, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32328775
4.
A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer.
Oncologist
; 24(12): 1512-e1267, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31383812
5.
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
N Engl J Med
; 375(3): 209-19, 2016 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27264120
6.
Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRI.
J Magn Reson Imaging
; 48(4): 971-981, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29630755
7.
A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.
Breast Cancer Res Treat
; 165(1): 97-107, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28560655
8.
A maximum-likelihood method to estimate a single ADC value of lesions using diffusion MRI.
Magn Reson Med
; 76(6): 1919-1931, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26743234
9.
Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
BMC Cancer
; 16: 500, 2016 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27430256
10.
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases.
Support Care Cancer
; 24(3): 1327-37, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26329397
11.
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
Support Care Cancer
; 24(1): 447-455, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26335402
12.
Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series.
Neurol Sci
; 36(9): 1691-3, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25990104
13.
A pilot study of estradiol followed by exemestane for reversing endocrine resistance in postmenopausal women with hormone receptor-positive metastatic breast cancer.
Oncologist
; 19(11): 1127-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25260365
14.
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515.
Blood
; 120(6): 1210-7, 2012 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-22734071
15.
Utility of Stereotactic Body Radiation Therapy in Establishing Local Control for Patients With Invasive Breast Cancer Not Undergoing Definitive Surgery.
Int J Radiat Oncol Biol Phys
; 118(2): 436-442, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37793576
16.
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid.
Cancer
; 119(4): 832-8, 2013 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22951813
17.
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid.
Support Care Cancer
; 21(12): 3497-507, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23975226
18.
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
Clin Cancer Res
; 29(24): 5021-5030, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37363965
19.
Osteoclast inhibition in postmenopausal breast cancer: Is the evidence too strong to ignore?
Cancer
; 123(13): 2392-2394, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28464216
20.
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer.
Breast Cancer Res Treat
; 134(1): 13-20, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22198412